Immediate Impact
47 standout
Citing Papers
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‐Stratification, and Management
2025 Standout
Works of Arie Apel being referenced
Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis
2022
Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Arie Apel | 154 | 157 | 74 | 164 | 26 | 400 | |
| Lohith Gowda | 161 | 177 | 58 | 174 | 35 | 419 | |
| Mónica Ballesteros | 93 | 100 | 75 | 77 | 24 | 387 | |
| Kamille A. West | 113 | 153 | 70 | 104 | 41 | 436 | |
| Sigrun Einarsdottir | 106 | 138 | 13 | 156 | 22 | 432 | |
| Radwan Massoud | 234 | 150 | 53 | 58 | 50 | 379 | |
| Thomas Chatzikonstantinou | 65 | 236 | 25 | 234 | 17 | 446 | |
| Najib Dally | 47 | 160 | 41 | 125 | 36 | 370 | |
| M Aker | 214 | 94 | 50 | 41 | 15 | 451 | |
| Shankara Paneesha | 129 | 179 | 35 | 72 | 38 | 420 | |
| Jérôme Razanamahery | 40 | 239 | 19 | 247 | 21 | 399 |
All Works
Login with ORCID to disown or claim papers
Loading papers...